Healthcare Reimbursement Market (By Claim: Underpaid, Full Paid; By Payers: Private Payers, Public Payers; By Service Provider: Physician office, Hospitals, Diagnostic Laboratories, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global healthcare reimbursement market size is anticipated to around USD 21.2 billion by 2026, this market is anticipated to grow 18.5% CAGR during the forecast time period. The industry is primarily driven by supportive government initiatives along with increasing cost of prescription medicines.

Market Dynamics

Increasing healthcare burden on emerged and emerging economies paired with favourable regulatory policies and also supportive reimbursement scenario has been main development stimulants for the healthcare reimbursement market.

There has been an ascent in the medicinal services cost in the U.S. when contrasted with normal yearly pay of the general population. The social insurance costs were USD 3.3 trillion of every 2016 that approaches 17.9% of the GDP. It expended 6.0% of the general salary in 2013. The U.S. financial misery has expanded the weight of social insurance costs on people and organizations. After presentation of the Obamacare Act, there was a decline in the out-of-stash wellbeing spending by 12.0% of all natives in a two-year range.

Market Insights

The U.S. Affordable Care Act emphases on controlling and reducing costs of healthcare. The law bolsters inventive strategies to convey therapeutic consideration to diminish social insurance expenses and makes reasonable medical coverage accessible to more individuals. Since the Obamacare became effective in 2014, the quantity of uninsured kids younger than 18 in the U.S. decreased to 5.0% in 2015 when contrasted with 9% in 2008.

Likewise, the Center for Medicare and Medicaid Services is moving in the direction of conveyance of solid brilliant consideration, support of productive outcomes in social insurance framework, and making health care coverage reasonable for many Americans who are looking for and getting inclusion. The Medicaid spending in the U.S. developed by 3.9% in 2016 or 17.0% of the aggregate National Health Expenditure. What's more, Medicare spending developed by 3.6% in 2016 or 20.0% of the aggregate National Health Expenditure.

Market Segmentation

Market By Claim

  • Underpaid
  • Full Paid

Market By Payers

  • Private Payers
  • Public Payers

Market By Service Provider

  • Physician office
  • Hospitals
  • Diagnostic Laboratories
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America commanded the market in 2018. It is anticipated to stay overwhelming all through the forth coming years. Nearness of solid repayment structure and an extensive number of protection players are the key patterns profiting the development of the market. Likewise, the Affordable Care Act in the U.S. makes its obligatory to have inclusion. The states that did not obey were punished by the government. Subsequently, it goes about as a main impetus for the territorial market.

Europe pursued North America in terms of market share. Expanding geriatric populace and in this manner rising perpetual illnesses, for example, cardiovascular sicknesses, respiratory infections, and atherosclerosis, are driving the market in this area. Over the previous decade, Western Europe's human services frameworks have grown quickly towards the appropriation of execution based repayment structures.

Market Participants

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with thehealthcare reimbursement areare The Blue Cross Blue Shield Association, UnitedHealth Group, WellCare Health Plans, Aviva, AgileHealthInsurance, Allianz, Nippon Life Insurance, CVS Health, Aetna, and BNP Paribas.


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary